Abstract:Background: Implantation of nonabsorbable polypropylene (PP) mesh in the vagina is the main surgical treatment for pelvic organ prolapse (POP); however, clinical outcomes remain controversial and far from satisfactory. In particular, reducing the exposure or erosion of vaginal implants to obtain improved functional reconstruction is challenging. There is an urgent need for the development of new materials and/or products for POP treatment. A nanofibrous biomimetic mesh was recently developed to address this issue. Objective: In this study, the basic properties of the newly developed mesh, including structural characteristics, mechanical properties, biological response of human umbilical cord mesenchymal stem cells in vitro, and tissue regeneration and biocompatibility in vivo, were evaluated and compared with those of Gynemesh (TM) PS.Methods: Scanning electron microscopy and uniaxial tensile methods were used to evaluate microstructure and mechanical properties, respectively. Mesenchymal stem cell growth on the meshes was observed by fluorescence microscopy to visualize the expression of enhanced red fluorescent protein. Twenty-four mature female Sprague Dawley rats were randomly assigned to two groups: group 1 (nanofibrous biomimetic mesh, Medprin, Germany, n=12) and group 2 (Gynemesh (TM) PS, Ethicon, USA; n=12). The posterior vaginal wall was incised from the introitus, and the mesh was then implanted. Three implants of each type were tested for 1, 4, 8 and 12 weeks. Connective tissue organization, inflammation, vascularization, and regenerated tissue were histologically assessed.Results: The nanofibrous biomimetic mesh is a relatively heavy material and exhibited lower porosity than Gynemesh (TM) PS. The new mesh was stiffer than Gynemesh (TM) PS (p < 0.001) but supported human umbilical cord mesenchymal stem cell attachment. Erosion of the grafts did not occur in any animal. The nanofibrous biomimetic mesh was encapsulated by a thicker layer of connective tissue and was associated with significantly greater inflammatory scores compared with Gynemesh (TM) PS. At 12 weeks, the vascularization of the new mesh was greater than that of Gynemesh (TM) PS (p < 0.05). No significant difference in the thickness of the smooth muscle layer following implantation was observed between the two groups (p > 0.05).Conclusions: The nanofibrous biomimetic mesh is a candidate for reinforcing pelvic reconstruction. The mesh could be improved by decreasing its weight and stiffness and increasing its porosity. This mesh could serve as a carrier for stem cells in future regenerative medicine and tissue engineering research. (C) 2016 Elsevier Ltd. All rights reserved.

3D Bioprinted Endometrial Stem Cells on Melt Electrospun PCL Meshes for Pelvic Floor Application Promote Anti-Inflammatory Responses in Mice

3D Printed Mesh Geometry Modulates Immune Response and Interface Biology in Mouse and Sheep Model: Implications for Pelvic Floor Surgery

3D Bio-Printed Endometrial Construct Restores the Full-Thickness Morphology and Fertility of Injured Uterine Endometrium.

Antibacterial Polymer Nanofiber-Coated and High Elastin Protein-Expressing BMSCs Incorporated Polypropylene Mesh for Accelerating Healing of Female Pelvic Floor Dysfunction

Optimizing melt electrowriting prototypes for printing non‐medical and medical grade polycaprolactone meshes in prolapse repair

A Novel 3D Printed Type II Silk Fibroin/polycaprolactone Mesh for the Treatment of Pelvic Organ Prolapse.

Oestradiol-releasing Biodegradable Mesh Stimulates Collagen Production and Angiogenesis: An Approach to Improving Biomaterial Integration in Pelvic Floor Repair

3D printing and development of computational models of biodegradable meshes for pelvic organ prolapse

Adipose Mesenchymal Stem Cell-Based Tissue Engineering Mesh with Sustained Bfgf Release to Enhance Tissue Repair.

Characterisation of Polycaprolactone Scaffolds Made by Melt Electrospinning Writing for Pelvic Organ Prolapse Correction- a Pilot Study

3D Printable Hydrogel with Tunable Degradability and Mechanical Properties as a Tissue Scaffold for Pelvic Organ Prolapse Treatment

Preclinical Animal Study and Human Clinical Trial Data of Co-Electrospun Poly(l-Lactide-co-caprolactone) and Fibrinogen Mesh for Anterior Pelvic Floor Reconstruction.

Tissue-engineered mesh for pelvic floor reconstruction fabricated from silk fibroin scaffold with adipose-derived mesenchymal stem cells

3D Printable Biopolymers as Pelvic Floor Scaffolds

Prussian Blue Nanoparticle-Entrapped GelMA Gels Laden with Mesenchymal Stem Cells as Prospective Biomaterials for Pelvic Floor Tissue Repair

Nanofibrous Biomimetic Mesh Can Be Used for Pelvic Reconstructive Surgery: A Randomized Study.

[Primary Fabrication of a Tissue-Engineered Mesh for Pelvic Floor Reconstruction and Research in Vivo].

Development of a cellulose-based prosthetic mesh for pelvic organ prolapse treatment: In vivo long-term evaluation in an ewe vagina model

Integration of Nondegradable Polystyrene and Degradable Gelatin in a Core-Sheath Nanofibrous Patch for Pelvic Reconstruction.

Effective Therapy of Endometrial Injury by Slow-Releasing Human Placenta-Derived Mesenchymal Stem Cells Encapsulated Within Hyaluronic Acid Hydrogels

Comparing Different Tissue-Engineered Repair Materials for the Treatment of Pelvic Organ Prolapse and Urinary Incontinence: Which Material is Better?